Trexquant Investment LP - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 112 filers reported holding NEVRO CORP in Q2 2015. The put-call ratio across all filers is 2.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$555,323
+64.0%
28,893
+116.9%
0.01%
+55.6%
Q2 2023$338,569
-43.6%
13,319
-19.8%
0.01%
-43.8%
Q1 2023$600,705
-82.8%
16,617
-81.2%
0.02%
-83.8%
Q4 2022$3,499,769
+291.9%
88,378
+333.8%
0.10%
+147.5%
Q2 2022$893,000
+23.9%
20,371
+128.9%
0.04%
-11.1%
Q4 2021$721,000
+248.3%
8,899
+498.9%
0.04%
+136.8%
Q1 2021$207,000
-71.7%
1,486
-75.7%
0.02%
-62.7%
Q2 2020$731,000
-19.8%
6,118
-32.9%
0.05%
-22.7%
Q1 2020$911,000
-22.4%
9,113
-8.8%
0.07%
-4.3%
Q4 2019$1,174,000
+15.3%
9,992
-15.6%
0.07%
-21.6%
Q3 2019$1,018,000
+173.7%
11,845
+106.7%
0.09%
+166.7%
Q2 2019$372,000
-73.5%
5,731
-74.5%
0.03%
-67.0%
Q1 2019$1,406,000
+44.4%
22,500
-10.1%
0.10%
+63.9%
Q4 2018$974,000
-18.2%
25,036
+19.9%
0.06%
-31.5%
Q3 2018$1,190,000
+180.7%
20,882
+266.8%
0.09%
-23.3%
Q2 2017$424,000
-59.3%
5,693
-48.7%
0.12%
-13.4%
Q1 2017$1,041,000
+29.5%
11,108
+44.3%
0.13%
-25.1%
Q3 2016$804,000
+148.9%
7,700
+61.0%
0.18%
+539.3%
Q4 2015$323,000
+50.2%
4,784
+2.3%
0.03%
+47.4%
Q3 2015$215,000
-78.7%
4,675
-75.1%
0.02%
-83.2%
Q2 2015$1,010,00018,8000.11%
Other shareholders
NEVRO CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Iron Triangle Partners LP 562,833$40,710,0004.84%
Altium Capital Management LP 77,000$5,569,0001.86%
PFM Health Sciences, LP 649,513$46,979,0001.76%
Rock Springs Capital Management LP 721,500$52,186,0001.31%
Integral Health Asset Management, LLC 50,000$3,617,0000.94%
Redmile Group, LLC 411,017$29,729,0000.93%
K2 PRINCIPAL FUND, L.P. 114,800$8,303,0000.72%
Connacht Asset Management LP 18,762$1,357,0000.70%
Perceptive Advisors 477,037$34,504,0000.69%
ArrowMark Colorado Holdings LLC 855,439$61,874,0000.54%
View complete list of NEVRO CORP shareholders